CAS: 247037-82-7 - Thiazole-2-carboxamidine hydrochloride
Fórmula:C4H5N3S·ClH
InChI:InChI=1S/C4H5N3S.ClH/c5-3(6)4-7-1-2-8-4;/h1-2H,(H3,5,6);1H
Clave InChI:InChIKey=MOIIOZOJYWYXEP-UHFFFAOYSA-N
SMILES:Cl.N=C(N)C1=NC=CS1
- Sinónimos:
- 2-Thiazolecarboximidamide hydrochloride
- 2-Thiazolecarboximidamide, hydrochloride (1:1)
- 2-Thiazolecarboximidamide, monohydrochloride
- Thiazole-2-carboxamidine hydrochloride
- 2-Thiazolecarboxamidine HCl
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | 2-Thiazolecarboxamidine Hydrochloride REF: IN-DA002P31CAS: 247037-82-7 | 98% | 24,00 €~324,00 € | Mar 26 Nov 24 |
 | Thiazole-2-carboximidamide hydrochloride REF: 10-F318312CAS: 247037-82-7 | 95.0% | A consultar | Mar 10 Dic 24 |
 | Thiazole-2-carboximidamide hydrochloride REF: 3D-FT140118CAS: 247037-82-7 | Min. 95% | A consultar | Mar 07 Ene 25 |
2-Thiazolecarboxamidine Hydrochloride
CAS:247037-82-7
Fórmula:
C4H6ClN3S
Pureza:
98%
Forma y color:
Solid
Peso molecular:
163.6285
Ref: IN-DA002P31
| 1g | 24,00 € | ||
| 5g | 53,00 € | ||
| 10g | 66,00 € | ||
| 25g | 122,00 € | ||
| 100g | 324,00 € | ||
| 250mg | 25,00 € |
Entrega estimada en Estados Unidos, el Martes 26 de Noviembre de 2024
Thiazole-2-carboximidamide hydrochloride
CAS:247037-82-7
Pureza:
95.0%
Forma y color:
Solid, White to Yellow Solid
Peso molecular:
163.6199951171875
Ref: 10-F318312
| 1g | A consultar | ||
| 5g | A consultar | ||
| 10g | A consultar | ||
| 25g | A consultar | ||
| 100g | A consultar | ||
| 250mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 10 de Diciembre de 2024
Thiazole-2-carboximidamide hydrochloride
CAS:247037-82-7
Thiazole-2-carboximidamide hydrochloride is a potent inhibitor of the human immunodeficiency virus type 1 (HIV-1) reverse …
Fórmula:
C4H6ClN3S
Pureza:
Min. 95%
Peso molecular:
163.63 g/mol
Ref: 3D-FT140118
| 1g | A consultar | ||
| 2g | A consultar | ||
| 5g | A consultar | ||
| 10g | A consultar | ||
| 500mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 7 de Enero de 2025
